FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2184449725> ?p ?o ?g. }

• W2184449725 endingPage "72" @default.
• W2184449725 startingPage "2561" @default.
• W2184449725 abstract "Asparaginases are the cornerstone therapy of many successful combination regimens for the treatment of acute lymphoblastic leukemia (ALL), the most common malignancy in children and adolescents. Currently, two asparaginase formulations are available in the US, native Escherichia coli asparaginase (ASNase) and pegaspargase. A third formulation native Erwinia asparaginase (Erwinase, ERW) has recently been made available under a licensing exception for personal use. We report here the development and validation process of ERW pharmacoanalytical assays and the results in a few patients.We developed and systematically validated the ERW enzyme activity and ERW concentration, anti-ERW antibody and related assays. Pharmacokinetic and pharmacodynamic (PK-PD) studies were performed in a limited number of patients who received 6,000 IU/m2 x 3 per week x 2 courses, and 4 patients who received 25,000 IU/m2 x 3 per week x 2 courses of ERW.The linearity and range of the Erwinase calibration lines for the pharmacoanalytical assays were excellent. The accuracy and precision were better than the FDA limit allows for oncology biological products (<30%) coefficient of variation (%CV) and related parameters in the quantification of ERW concentration. The validation of these parameters was equal to or better than during the assay development. PK-PD analyses of ERW in a few patients yielded an average half-life of elimination of 15.8+/-1.64 hours. There was an excellent PD response post ERW administration resulting in an ERW concentration-dependent asparagine (ASN, <0.5 microM) and glutamine (GLN, <50 microM) deamination. Pharmacodynamic correlations demonstrated that 0.1 to 0.2 IU/ml of ERW in serum were sufficient for 90% GLN and/or ASN deamination for up to 2 weeks. No anti-ERW antibody [Ab(+)] was seen among those few patients. None of the other 5 patients had an adverse event. Based on these post hoc results, simulations on various doses and schedules of this drug have been made.The pharmacoanalytical assays were excellent tools to evaluate the PK and PD data of ERW in pediatric patients with HR ALL. However, this initial PK-PD evidence needs further validation in future clinical trials. Insights into the PD contributions of ERW in anti-E. coli ASNase Ab(+) patients will guide us in optimal design and use of ERW as part of combination chemotherapy regimens in future clinical trials." @default.
• W2184449725 created "2016-06-24" @default.
• W2184449725 creator A5025288612 @default.
• W2184449725 creator A5050912150 @default.
• W2184449725 creator A5071056027 @default.
• W2184449725 creator A5079670536 @default.
• W2184449725 date "2007-08-19" @default.
• W2184449725 modified "2023-10-18" @default.
• W2184449725 title "Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models." @default.
• W2184449725 cites W1526681768 @default.
• W2184449725 cites W1594041322 @default.
• W2184449725 cites W1887163125 @default.
• W2184449725 cites W1940732706 @default.
• W2184449725 cites W1970593462 @default.
• W2184449725 cites W198182894 @default.
• W2184449725 cites W1989179393 @default.
• W2184449725 cites W2005753411 @default.
• W2184449725 cites W2016833582 @default.
• W2184449725 cites W2024893955 @default.
• W2184449725 cites W2028187888 @default.
• W2184449725 cites W2028579560 @default.
• W2184449725 cites W2037808957 @default.
• W2184449725 cites W2043239876 @default.
• W2184449725 cites W2053852136 @default.
• W2184449725 cites W2086930991 @default.
• W2184449725 cites W2117623554 @default.
• W2184449725 cites W2326181393 @default.
• W2184449725 cites W2397445751 @default.
• W2184449725 cites W87736676 @default.
• W2184449725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17695416" @default.
• W2184449725 hasPublicationYear "2007" @default.
• W2184449725 type Work @default.
• W2184449725 sameAs 2184449725 @default.
• W2184449725 citedByCount "10" @default.
• W2184449725 countsByYear W21844497252012 @default.
• W2184449725 countsByYear W21844497252013 @default.
• W2184449725 countsByYear W21844497252015 @default.
• W2184449725 countsByYear W21844497252016 @default.
• W2184449725 countsByYear W21844497252023 @default.
• W2184449725 crossrefType "journal-article" @default.
• W2184449725 hasAuthorship W2184449725A5025288612 @default.
• W2184449725 hasAuthorship W2184449725A5050912150 @default.
• W2184449725 hasAuthorship W2184449725A5071056027 @default.
• W2184449725 hasAuthorship W2184449725A5079670536 @default.
• W2184449725 hasConcept C111113717 @default.
• W2184449725 hasConcept C112705442 @default.
• W2184449725 hasConcept C126322002 @default.
• W2184449725 hasConcept C2778461978 @default.
• W2184449725 hasConcept C2778904437 @default.
• W2184449725 hasConcept C2908647359 @default.
• W2184449725 hasConcept C2909962599 @default.
• W2184449725 hasConcept C71924100 @default.
• W2184449725 hasConcept C98274493 @default.
• W2184449725 hasConcept C99454951 @default.
• W2184449725 hasConceptScore W2184449725C111113717 @default.
• W2184449725 hasConceptScore W2184449725C112705442 @default.
• W2184449725 hasConceptScore W2184449725C126322002 @default.
• W2184449725 hasConceptScore W2184449725C2778461978 @default.
• W2184449725 hasConceptScore W2184449725C2778904437 @default.
• W2184449725 hasConceptScore W2184449725C2908647359 @default.
• W2184449725 hasConceptScore W2184449725C2909962599 @default.
• W2184449725 hasConceptScore W2184449725C71924100 @default.
• W2184449725 hasConceptScore W2184449725C98274493 @default.
• W2184449725 hasConceptScore W2184449725C99454951 @default.
• W2184449725 hasIssue "4C" @default.
• W2184449725 hasLocation W21844497251 @default.
• W2184449725 hasOpenAccess W2184449725 @default.
• W2184449725 hasPrimaryLocation W21844497251 @default.
• W2184449725 hasRelatedWork W1752921906 @default.
• W2184449725 hasRelatedWork W1997101420 @default.
• W2184449725 hasRelatedWork W2365600738 @default.
• W2184449725 hasRelatedWork W2372895781 @default.
• W2184449725 hasRelatedWork W2463984306 @default.
• W2184449725 hasRelatedWork W2477866235 @default.
• W2184449725 hasRelatedWork W2574720511 @default.
• W2184449725 hasRelatedWork W3128674376 @default.
• W2184449725 hasRelatedWork W3205517375 @default.
• W2184449725 hasRelatedWork W3207379667 @default.
• W2184449725 hasVolume "27" @default.
• W2184449725 isParatext "false" @default.
• W2184449725 isRetracted "false" @default.
• W2184449725 magId "2184449725" @default.
• W2184449725 workType "article" @default.